XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Changes in Stockholders’ Deficit - USD ($)
shares in Thousands, $ in Thousands
Total
Stock Issuance in Connection with Emergence
Stock Issuance for Equity Rights Offering
Issuance of new common stock for the Equity Rights Offering backstop commitment
Issuance of new common stock for Bitmain obligation
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Common Stock
Stock Issuance in Connection with Emergence
Common Stock
Stock Issuance for Equity Rights Offering
Common Stock
Issuance of new common stock for the Equity Rights Offering backstop commitment
Common Stock
Issuance of new common stock for Bitmain obligation
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional
Paid-In Capital
Additional
Paid-In Capital
Stock Issuance in Connection with Emergence
Additional
Paid-In Capital
Stock Issuance for Equity Rights Offering
Additional
Paid-In Capital
Issuance of new common stock for the Equity Rights Offering backstop commitment
Additional
Paid-In Capital
Issuance of new common stock for Bitmain obligation
Additional
Paid-In Capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated
Deficit
Accumulated
Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated
Deficit
Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Dec. 31, 2022               375,225                            
Beginning balance at Dec. 31, 2022 $ (409,346)             $ 36           $ 1,764,368           $ (2,173,750)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                            
Net loss (50,794)                                     (50,794)    
Stock-based compensation 41,414                         41,414                
Restricted stock awards issued, net of tax withholding obligations (in shares)               11,020                            
Restricted stock awards forfeited (in shares)               (377)                            
Ending balance (in shares) at Sep. 30, 2023               385,868                            
Ending balance at Sep. 30, 2023 $ (418,726)             $ 36           1,805,782           (2,224,544)    
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2023-08 [Member]                                          
Beginning balance (in shares) at Dec. 31, 2022               375,225                            
Beginning balance at Dec. 31, 2022 $ (409,346)             $ 36           1,764,368           (2,173,750)    
Ending balance (in shares) at Dec. 31, 2023 386,883             386,883         386,883                  
Ending balance at Dec. 31, 2023 $ (596,941)         $ 24 $ (596,917) $ 36         $ 36 1,823,260         $ 1,823,260 (2,420,237) $ 24 $ (2,420,213)
Beginning balance (in shares) at Jun. 30, 2023               379,091                            
Beginning balance at Jun. 30, 2023 (392,441)             $ 36           1,790,921           (2,183,398)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                            
Net loss (41,146)                                     (41,146)    
Stock-based compensation 14,861                         14,861                
Restricted stock awards issued, net of tax withholding obligations (in shares)               7,154                            
Restricted stock awards forfeited (in shares)               (377)                            
Ending balance (in shares) at Sep. 30, 2023               385,868                            
Ending balance at Sep. 30, 2023 $ (418,726)             $ 36           1,805,782           (2,224,544)    
Beginning balance (in shares) at Dec. 31, 2023 386,883             386,883         386,883                  
Beginning balance at Dec. 31, 2023 $ (596,941)         $ 24 $ (596,917) $ 36         $ 36 1,823,260         $ 1,823,260 (2,420,237) $ 24 $ (2,420,213)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                            
Net loss (1,049,464)                                     (1,049,464)    
Stock-based compensation 27,957                         27,957                
Cancellation of common stock in connection with emergence (in shares)               (386,883)                            
Cancellation of common stock in connection with emergence 0             $ (36)           36                
Issuance of new common stock (in shares)                 152,576 15,649 2,111 10,735                    
Issuance of new common stock   $ 296,895 $ 55,000 $ 5,475 $ 27,839       $ 2           $ 296,893 $ 55,000 $ 5,475 $ 27,839        
Conversion premium on the issuance of the New Secured Convertible Notes 33,202                         33,202                
Issuance of warrants (345,856)                         (345,856)                
Exercise of stock options 9                         9                
Restricted stock awards issued, net of tax withholding obligations (in shares)               1,624                            
Restricted stock awards issued, net of tax withholding obligations (3,390)                         (3,390)                
Restricted stock awards forfeited (in shares)               (40)                            
Exercise of warrants (in shares)               51,699                            
Exercise of warrants 554,406             $ 1           554,405                
Issuance of new common stock for New Secured Convertible Notes conversion (in shares)               44,585                            
Issuance of new common stock for New Secured Convertible Notes conversion 261,772                         261,772                
Issuance of new common stock for PIK interest (in shares)               882                            
Issuance of new common stock for PIK interest $ 3,677                         3,677                
Ending balance (in shares) at Sep. 30, 2024 279,821             279,821                            
Ending balance at Sep. 30, 2024 $ (729,395)             $ 3           2,740,279           (3,469,677)    
Beginning balance (in shares) at Jun. 30, 2024               187,892                            
Beginning balance at Jun. 30, 2024 (1,083,874)             $ 2           1,930,542           (3,014,418)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                            
Net loss (455,259)                                     (455,259)    
Stock-based compensation 20,523                         20,523                
Conversion premium on the issuance of the New Secured Convertible Notes                           33,200                
Restricted stock awards issued, net of tax withholding obligations (in shares)               224                            
Restricted stock awards issued, net of tax withholding obligations 2                         2                
Exercise of warrants (in shares)               51,645                            
Exercise of warrants 553,986             $ 1           553,985                
Issuance of new common stock for New Secured Convertible Notes conversion (in shares)               40,060                            
Issuance of new common stock for New Secured Convertible Notes conversion $ 235,227                         235,227                
Ending balance (in shares) at Sep. 30, 2024 279,821             279,821                            
Ending balance at Sep. 30, 2024 $ (729,395)             $ 3           $ 2,740,279           $ (3,469,677)